Oxcarbazepine in rapid benzodiazepine detoxification

American Journal of Drug and Alcohol Abuse

Volumn 34, Issue 5, 2008, Pages 534-540

  Croissant, Bernhard ^a   Grosshans, Martin ^b   Diehl, Alexander ^b   Mann, Karl ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Benzodiazepine detoxification; Carbamazepine; Dosage scheme; Oxcarbazepine; Withdrawal symptoms

Indexed keywords

BENZODIAZEPINE; DIAZEPAM; OXCARBAZEPINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DETOXIFICATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HOSPITAL PATIENT; HUMAN; LOW DRUG DOSE; MALE; WITHDRAWAL SYNDROME;

ADULT; AGED, 80 AND OVER; ANTICONVULSANTS; BENZODIAZEPINES; CARBAMAZEPINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS; TREATMENT OUTCOME;

EID: 52949109705     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.1080/00952990802149021     Document Type: Article

References (21)

1. O'Brien CP. Benzodiazepine use, abuse, and dependence. J Clin Psychiatry 66, Suppl 2005; 2:28-33.
2. Rickels K, Schweizer E, Garcia Espana F, Case G, DeMartinis N, Greenblatt D. Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: Effects onwithdrawal symptoms and taper outcome. Psychopharmacology 1999; 141:1-5.
3. Di Costanzo E, Rovea A. The prophylaxis of benzodiazepine withdrawal syndrome in the elderly: The effectiveness of carbamazepine. Double-blind study vs. placebo. Minerva Psichiatr 1992; 33:301-304.
4. Zullino DF, Khazaal Y, Hattenschwiler J, Borgeat F, Besson J. Anticonvulsant drugs in the treatment of substance withdrawal. Drugs Today 2004; 40: 603-619.
5. Schmidt D, Elger CE. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs? Epilepsy Behav 2004; 5:627-635.
6. Beydoun A. Safety and efficacy of oxcarbazepine: Results of randomized, double-blind trials. Pharmacotherapy 2000; 20:152-158.
7. Pellock JM. Treatment of epilepsy in the new millennium. Pharmacotherapy 2000; 20:129-138.
8. Beydoun A, Kutluay E. Oxcarbazepine. Expert Opin Pharmacother 2002; 3:59-71.
9. Croissant B, Scherle T, Diehl A, Heinz A, Mann K. Oxcarbazepine in alcohol relapse prevention - A Case Series. Pharmacopsychiat 2004; 37:306-307.
10. Croissant B, Diehl A, Klein O, Zambrano S, Nakovics H, Heinz A, Mann K. A pilot study of Oxcarbazepine vs. Acamprosate in alcohol-dependent patients. Alcohol Clin Exp Res 2006; 30:630-635.
11. Martinotti G, Di Nicola M, Romanelli R, Andreoli S, Pozzi G, Moroni N, Janiri L. High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol-dependent patients. Hum Psychopharmacol 2007; 22:149-156.
12. Martinotti G, Romanelli R, Di Nicola M, Reina D, Mazza M, Janiri L. Oxcarbazepine at high dosages for the treatment of alcohol dependence. Am J Addict 2007; 16:247-248.
13. Koethe D, Juelicher A, Nolden BM, Braunwarth WD, Klosterkötter J, Niklewski G, Wodarz N, Klatt J, Burtscheidt W, Gaebel W, Leweke FM. Oxcarbazepine - Efficacy and tolerability during treatment of alcohol withdrawal. A double-blind, randomized, placebo-controlled multicenter pilot study. Alcohol Clin Exp Res 2007; 31:1188-1194.
14. Hermann D, Klages E, Croissant B. Oxcarbazepine in outpatient benzodiazepine withdrawal in polytoxicomanic patients during an opiate maintenance therapy. Psychopharmakotherap 2005; 12:97-99.
15. Croissant B, Grosshans M, Klein O, Diehl A, Mann K. Scheme-based Benzodiazepine detoxification with Oxcarbazepine - A case report. Pharmacopsychiatry 2005; 38(5):222-223.
16. Ashton CH. Benzodiazepine abuse. In Drinks, Drugs and Dependence: From Science to Clinical Practice. Caan W, De Belleroche J, eds. London: Routledge, 2002; 197-212.
17. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: The revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 1989; 84:1353-1357.
18. Laux G, König W. Benzodiazepine abuse - Findings from a German state mental hospital. Schweiz Med Prax 1989; 78:779-783.
19. Dietrich DE, Kropp S, Emrich HM. Oxcarbazepine in affective and schizoaffective disorders. Pharmacopsychiat 2001; 34:242-250.
20. Ghaemi SN, Berv DA, Klugman J, Rosenquist KJ, Hsu DJ. Oxcarbazepine treatment of bipolar disorder. J Clin Psychiatry 2003; 64:943-945.
21. Ashton CH. The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry 2005; 28:249-255.